What is the recommended interval between pregnancy (or delivery) and restarting systemic and topical retinoids, such as isotretinoin, acitretin, and topical tretinoin?

Recommended Interval Between Pregnancy and Retinoid Use

For systemic isotretinoin, wait 1 month after stopping treatment before attempting pregnancy; for acitretin, wait 3 years after stopping treatment before attempting pregnancy. For topical retinoids, no waiting period is required after delivery before resuming use.

Systemic Retinoids

Isotretinoin

The FDA label explicitly requires contraception for 1 month after discontinuing isotretinoin therapy 11. This means:

• Pregnancy testing should occur at completion of isotretinoin course and again one month later 1
• Two forms of effective contraception must continue for one month after stopping treatment 11
• After delivery, isotretinoin can be restarted once pregnancy is excluded, though breastfeeding is contraindicated

The 1-month washout period is based on isotretinoin's relatively short elimination half-life, allowing the drug to clear from the system quickly.

Acitretin

Acitretin requires a dramatically longer waiting period of 3 years after stopping treatment before pregnancy can be safely attempted 2. This extended timeframe is critical because:

• Acitretin can be converted to etretinate, which has an extremely prolonged elimination half-life
• Alcohol consumption increases this conversion, making the risk even more persistent 2
• Strict contraception must be maintained for the entire 3-year period 2
• Patients must abstain from alcohol during and after treatment to minimize etretinate formation 2

The British Association of Dermatologists guidelines emphasize that acitretin should be avoided entirely in women of childbearing potential when suitable alternatives exist 2.

Topical Retinoids

Topical retinoids (tretinoin, adapalene, tazarotene, trifarotene) do not require any waiting period after delivery before resuming use. Recent high-quality Nordic cohort data from 2025 involving nearly 4 million births found no increased risk of major congenital malformations with first-trimester topical retinoid exposure (aRR 1.1,95% CI 0.87-1.38) 3.

While topical retinoids are avoided during pregnancy as a precautionary measure due to the known teratogenicity of systemic isotretinoin, the evidence does not support requiring a washout period after delivery. The systemic absorption of topical retinoids is minimal compared to oral formulations.

Critical Distinctions

The waiting period applies to stopping retinoids before pregnancy, not after delivery:

• If a patient was on isotretinoin and becomes pregnant, stop immediately and wait 1 month after last dose before attempting pregnancy again 1
• If a patient completed pregnancy and wants to restart retinoids, this can occur postpartum (avoiding breastfeeding with systemic retinoids)
• The teratogenic risk is to the developing fetus during organogenesis, not to future pregnancies after the drug has cleared

Common Pitfalls

Do not confuse the direction of timing: The mandatory waiting periods (1 month for isotretinoin, 3 years for acitretin) apply when stopping treatment before attempting conception, not when restarting after delivery. After giving birth, retinoids can be restarted once pregnancy is excluded and breastfeeding considerations are addressed, as there is no residual teratogenic risk to future pregnancies once the drug has been eliminated from the body.